From IR:
I understand your frustrations and concern. I can assure you we are working diligently to find better financing for the Company that would ease the dilution and therefore not put as much pressure on the stock price. As you know, we have used convertible note financing for the past few years, which can be very difficult to work through, since more traditional means of financing have not been available to us. In the meantime, we acquired two revenue-generating businesses at the end of 2015, to help us minimize our reliance on convertible note structures. However, until we can sustain the company with cash from operations and/or find a strategic investor for Firefly Dx that provides non-dilutive capital to help us find the remaining development for that product, we will likely have to continue to rely on the same types of convertible note financing.
As a follower of the company, I imagine you know that we try to communicate with our investors often, through press releases, SEC filings, investor conferences, and conference calls. I expect we will probably have information to relay relatively soon regarding our outlook for 2017.
Regards,
Allison Tomek
